Free Trial

Uniphar (UPR) Competitors

GBX 214
+1.00 (+0.47%)
(As of 07:32 AM ET)

UPR vs. UDG, ONT, GNS, CLIN, EMIS, VEC, SPI, CTH, INDV, and ERGO

Should you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), Oxford Nanopore Technologies (ONT), Genus (GNS), Clinigen Group (CLIN), EMIS Group (EMIS), Vectura Group (VEC), Spire Healthcare Group (SPI), CareTech (CTH), Indivior (INDV), and Ergomed (ERGO). These companies are all part of the "medical" sector.

Uniphar vs.

Uniphar (LON:UPR) and UDG Healthcare (LON:UDG) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

Uniphar has a net margin of 1.69% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.91% beat UDG Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Uniphar1.69% 13.91% 3.76%
UDG Healthcare N/A N/A N/A

Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Uniphar£2.68B0.21£45.17M£0.141,500.00
UDG Healthcare£1.25B2.18N/A£25.4042.48

UDG Healthcare received 513 more outperform votes than Uniphar when rated by MarketBeat users. However, 100.00% of users gave Uniphar an outperform vote while only 74.68% of users gave UDG Healthcare an outperform vote.

CompanyUnderperformOutperform
UnipharOutperform Votes
6
100.00%
Underperform Votes
No Votes
UDG HealthcareOutperform Votes
519
74.68%
Underperform Votes
176
25.32%

Uniphar currently has a consensus price target of GBX 310, suggesting a potential upside of 47.62%. Given Uniphar's higher probable upside, analysts plainly believe Uniphar is more favorable than UDG Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Uniphar
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
UDG Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

45.9% of Uniphar shares are owned by institutional investors. 10.1% of Uniphar shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. UDG Healthcare pays an annual dividend of GBX 0.17 per share and has a dividend yield of 0.0%. Uniphar pays out 1,428.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend.

In the previous week, UDG Healthcare's average media sentiment score of 0.45 beat Uniphar's score of 0.00 indicating that UDG Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
Uniphar Neutral
UDG Healthcare Neutral

Summary

Uniphar beats UDG Healthcare on 11 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPR vs. The Competition

MetricUnipharMedical Distribution IndustryMedical SectorLON Exchange
Market Cap£573.34M£19.51B£5.46B£1.39B
Dividend Yield0.72%1.19%4.39%11.71%
P/E Ratio1,500.00104.70104.851,558.01
Price / Sales0.2160.181,234.02178,521.79
Price / Cash9.9711.9637.9832.90
Price / Book1.642.144.702.83
Net Income£45.17M£1.15B£114.72M£152.69M
7 Day Performance-0.94%-0.17%-0.92%-0.15%
1 Month Performance-4.55%125.57%14.17%2.60%
1 Year Performance12.30%-5.20%23.82%93.00%

Uniphar Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPR
Uniphar
N/AGBX 214
+0.5%
GBX 310
+44.9%
+10.5%£584.26M£2.68B1,528.573,000
UDG
UDG Healthcare
N/AGBX 1,079
flat
N/AN/A£2.72B£1.25B42.489,000
ONT
Oxford Nanopore Technologies
2.362 of 5 stars
GBX 146.07
-3.1%
GBX 235.50
+61.2%
-25.9%£1.37B£167.75M-730.331,238
GNS
Genus
1.003 of 5 stars
GBX 2,055
-4.6%
GBX 2,150
+4.6%
-7.0%£1.35B£668.80M17,125.00480News Coverage
CLIN
Clinigen Group
N/AGBX 925
flat
N/A+0.0%£1.23B£565.60M64.691,000News Coverage
EMIS
EMIS Group
N/AGBX 1,920
flat
N/A+0.3%£1.23B£176.86M4,085.111,560
VEC
Vectura Group
N/AGBX 164.80
flat
N/AN/A£1.01B£190.60M8.209,200
SPI
Spire Healthcare Group
2.6163 of 5 stars
GBX 227
-0.9%
GBX 301.33
+32.7%
+4.6%£916.67M£1.44B3,242.86420
CTH
CareTech
N/AGBX 750
+0.3%
N/A+0.0%£850.02M£495.40M10,714.2911,000News Coverage
INDV
Indivior
2.9133 of 5 stars
GBX 579.20
-19.4%
GBX 1,500
+159.0%
-65.4%£750.47M£1.15B-742.561,000News Coverage
Positive News
ERGO
Ergomed
N/AGBX 1,346
flat
N/A+0.3%£701.00M£152.09M4,641.386

Related Companies and Tools


This page (LON:UPR) was last updated on 10/11/2024 by MarketBeat.com Staff
From Our Partners